1361 related articles for article (PubMed ID: 6189908)
21. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of glucocorticoid action on murine natural killer cell activity.
Cox WI; Holbrook NJ; Friedman H
J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
[TBL] [Abstract][Full Text] [Related]
23. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
Blanca I; Herberman RB; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671
[TBL] [Abstract][Full Text] [Related]
24. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
[TBL] [Abstract][Full Text] [Related]
25. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
26. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
Hiserodt JC; Britvan L; Targan SR
J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
[TBL] [Abstract][Full Text] [Related]
27. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
[TBL] [Abstract][Full Text] [Related]
28. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
Bukowski JF; Biron CA; Welsh RM
J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
[TBL] [Abstract][Full Text] [Related]
29. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells.
Saxena RK; Saxena QB; Adler WH
J Immunol; 1988 Sep; 141(5):1782-7. PubMed ID: 2457628
[TBL] [Abstract][Full Text] [Related]
30. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
31. Role of interferon in human natural killer activity against target cells infected with HSV-1.
Bishop GA; Glorioso JC; Schwartz SA
J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
[TBL] [Abstract][Full Text] [Related]
32. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction.
Sharma BS; Mhaskar S; Balazs L; Jin A; Smee DF
Immunopharmacol Immunotoxicol; 1992; 14(1-2):21-38. PubMed ID: 1375956
[TBL] [Abstract][Full Text] [Related]
35. Renewal of natural killer cells in mice having elevated natural killer cell activity.
Nassiry L; Miller SC
Nat Immun Cell Growth Regul; 1987; 6(5):250-9. PubMed ID: 3444438
[TBL] [Abstract][Full Text] [Related]
36. YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.
Wright SC; Bonavida B
Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1688-92. PubMed ID: 6572932
[TBL] [Abstract][Full Text] [Related]
37. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
Flexman JP; Shellam GR
Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
39. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
40. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
Bukowski JF; Welsh RM
J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
